Outcomes for propensity-matched patients who received myeloablative conditioning. For patients that received myeloablative conditioning, the HR for MUDs compared with Haplos: (A) OS was 0.99 (95% CI, 0.59-1.48), (B) DFS was 1.10 (95% CI, 0.74-1.60), (C) relapse was 1.12 (95% CI, 0.68-1.85), (D) NRM was 1.07 (95% CI, 0.52-1.82), (E) grade 3 to 4 aGVHD was 0.63 (95% CI, 0.10-1.20), and (F) cGVHD was 0.66 (95% CI, 0.43-1.08). BM/PB, bone marrow/peripheral blood; Condition, conditioning; HCT, recipient Sorror comorbidity score; Recip. CMV, recipient CMV status.